profile-img
NEJM

@NEJM

The New England Journal of Medicine (https://t.co/YGfDrRsIhE) is the world’s leading medical journal and website.

calendar_today23-03-2009 04:10:07

28,6K Tweets

932,2K Followers

419 Following

NEJM(@NEJM) 's Twitter Profile Photo
NEJM
@NEJM

1 year ago

Late breaking at : In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than chemotherapy alone. nej.md/3FJ4J3R

Late breaking at #SGOMtg: In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than chemotherapy alone. nej.md/3FJ4J3R
account_circle